Clinical trial
Nexium Dyspepsia/AST
NCT00251992 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00251992 |
|---|---|
| Title | Nexium Dyspepsia/AST |
| Official title | Supportive Test for Acid-Related Symptoms (STARS II) With Esomeprazole and a Following 7-week, Double-blind, Randomized, Placebo Controlled Treatment Period in Uninvestigated Subjects With Upper Gastrointestinal Symptoms. |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastrointestinal Disease, Signs and Symptoms, Digestive, Dyspepsia |
| Intervention type | Drug |
| Interventions | Esomeprazole |
| Enrollment | 1,200 |
| Start date | Dec 1, 2002 |
| Primary completion | Jan 1, 2005 |
| Completion | Jan 1, 2005 |
| First posted | Nov 11, 2005 |
| Last update posted | Jan 24, 2011 |
| Countries | Austria, Belgium, Canada, Finland, France, Germany, Hungary, Mexico, Norway, South Africa, Sweden, Switzerland and 1 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: